Multibic

Sodium hydrogen carbonate, the active ingredient in Multibic, is an electrolyte replenisher presented as a sterile injectable solution for intravenous and haemodialysis use. It is combined with magnesium chloride hexahydrate, sodium chloride and calcium chloride dihydrate to provide balanced electrolytes during renal replacement therapy. GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Multibic is employed in renal replacement and critical‑care settings to manage electrolyte and acid‑base disturbances. - Metabolic acidosis: helps correct low blood pH during dialysis or acute care. - Electrolyte imbalance: restores sodium, chloride, calcium and magnesium levels in patients undergoing haemodialysis. - Calcium supplementation: provides calcium ions to support cardiac and neuromuscular function during dialysis sessions.

Multibic may cause a range of adverse reactions, most of which are related to electrolyte shifts or infusion‑related events.

Common Side Effects: - Hypernatremia: elevated blood sodium levels. - Hypercalcemia: increased calcium concentration. - Hypermagnesemia: excess magnesium in serum. - Metabolic alkalosis: over‑correction of acidosis. - Hypotension: drop in blood pressure during infusion. - Nausea or vomiting.

Serious or Rare Side Effects: - Severe electrolyte disturbances leading to cardiac arrhythmia. - Volume overload causing pulmonary edema. - Anaphylactic or severe hypersensitivity reaction. - Acute respiratory distress syndrome (ARDS). - Central nervous system toxicity (e.g., seizures) due to extreme electrolyte imbalance.

When using Multibic, clinicians should observe several safety measures to minimize risk. - Assess baseline electrolyte and acid‑base status: obtain serum labs before infusion. - Monitor blood pressure and heart rhythm continuously during administration. - Adjust dialysis prescription: tailor bicarbonate and electrolyte concentrations to patient needs. - Avoid in patients with documented hypercalcemia or severe hypermagnesemia. - Use with caution in heart‑failure or fluid‑overload states. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Multibic can interact with other agents that affect electrolyte balance or acid‑base status.

Major Interactions (Avoid): - Concurrent intravenous calcium salts: risk of severe hypercalcemia. - Additional bicarbonate‑containing solutions: may cause profound metabolic alkalosis. - High‑dose loop diuretics: can precipitate rapid electrolyte shifts.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance potassium retention. - NSAIDs: can affect renal handling of electrolytes. - Potassium‑sparing diuretics: monitor for combined electrolyte effects.